08/08/2025
**FDA Approves Revolutionary Eye Drops for Age-Related Near Vision Loss**
A new eye drop called **VIZZ**, developed by **LENZ Therapeutics**, has received FDA approval as a breakthrough treatment for **presbyopia**, a common age-related condition that makes it difficult to focus on close-up objects. With over **128 million American adults** affected, this innovation provides a glasses-free solution for clearer near vision.
# # # **How VIZZ Works**
Unlike reading glasses, VIZZ uses a unique mechanism that **temporarily tightens the iris muscle**, creating a natural "pinhole" effect in the eye. This sharpens near vision **without blurring distance vision** or causing nearsightedness. Users can expect results within **30 minutes**, with effects lasting **up to 10 hours**—making it a convenient all-day solution.
# # # **Proven Effectiveness & Safety**
In **three Phase 3 clinical trials** involving more than **680 participants**, VIZZ demonstrated significant improvement in reading small print and performing close-up tasks. Safety data from over **30,000 treatment days** showed no serious side effects, confirming its reliability for daily use.
# # # **Availability**
VIZZ is expected to launch in **late 2025**, offering millions of people a simple, drug-based alternative to reading glasses. This approval marks a major step forward in **vision care technology**, providing a hassle-free option for those struggling with age-related near vision loss.
